BMN-293

N/A

Report date: 2024/08/22 18:00:23

Base Information

Drug NameBMN-293
Drug Alias NameDiNA-001BMN-293DINA-001/ADINA-001/BBMN 293
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMyosin-binding protein C, cardiac-type gene transference
TargetsMyosin-binding protein C, cardiac-type
Therapy Area/IndicationsCardiomyopathy, HypertrophicCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDinaqor AG
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical IncDinaqor AG
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, HypertrophicCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A